OnLume Overview

  • Founded
  • 2015
  • Status
  • Private
  • Employees
  • 8
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $6.94M
Latest Deal Amount
  • Investors
  • 3

OnLume General Information


Developer of a medical device intended to offer intuitive and ergonomic technologies for precise fluorescence image-guided surgery. The company's device offers intraoperative applications in perfusion imaging in reconstructive and burns surgery, cancer margin imaging, and nerve avoidance, enabling surgeons to get access to critical information on tissue types, features and function in real-time during surgery through fluorescence.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Decision/Risk Analysis
Primary Office
  • 3300 Commercial Avenue
  • Madison, WI 53714
  • United States
+1 (888) 000-0000

OnLume Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OnLume Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) 06-Jan-2021 $6.94M 00.000 Completed Startup
5. Grant 02-Oct-2020 000 00.000 Completed Startup
4. Early Stage VC (Series A) 18-Feb-2020 Cancelled Startup
3. Early Stage VC (Series AA) 26-Aug-2019 00.000 00.000 00.00 Completed Startup
2. Grant 28-Nov-2016 $300K Completed Startup
1. Capitalization Completed Startup
To view OnLume’s complete valuation and funding history, request access »

OnLume Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series AA 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
To view OnLume’s complete cap table history, request access »

OnLume Executive Team (5)

Name Title Board Seat Contact Info
James Bowman Chief Executive Officer
Andreas Velten Ph.D Co-Founder, Co-Chief Technology Officer & Board Member
Adam Uselmann Ph.D Co-Founder, Co-Chief Technology Officer, President & Board Member
Benjamin Titz Ph.D Co-Founder, Chief Scientific Officer & Board Member
Thomas Mackie Ph.D Co-Founder & Chairman
To view OnLume’s complete executive team members history, request access »

OnLume Board Members (6)

Name Representing Role Since
Adam Uselmann Ph.D OnLume Co-Founder, Co-Chief Technology Officer, President & Board Member 000 0000
Andreas Velten Ph.D OnLume Co-Founder, Co-Chief Technology Officer & Board Member 000 0000
Benjamin Titz Ph.D Self Co-Founder, Chief Scientific Officer & Board Member 000 0000
Carl Gulbrandsen OnLume Board Member 000 0000
Kevin Eliceiri Ph.D OnLume Co-Founder, Board Member & Scientific Advisor 000 0000
You’re viewing 5 of 6 board members. Get the full list »

OnLume Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OnLume Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Cancer Institute Government 000 0000 000000 0
Wisconsin Investment Partners Venture Capital Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
To view OnLume’s complete investors history, request access »